VCEL Q1 2025 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$53M+2.6% YoY

Gross Profit

$36M69.0% margin

Operating Income

-$13M-24.3% margin

Net Income

-$11M-21.4% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-30.2%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$425M

Total Liabilities

$129M

Stockholders' Equity

$295M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$51M	+2.6%
Gross Profit	$36M	$35M	+2.6%
Operating Income	-$13M	-$5M	-134.1%
Net Income	-$11M	-$4M	-191.2%

Revenue Segments

MACI Implants And Kits

$46M100%